Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Takayuki Shimo"'
Autor:
Tsuyoshi Shimmura, Tomoya Nakayama, Ai Shinomiya, Shoji Fukamachi, Masaki Yasugi, Eiji Watanabe, Takayuki Shimo, Takumi Senga, Toshiya Nishimura, Minoru Tanaka, Yasuhiro Kamei, Kiyoshi Naruse, Takashi Yoshimura
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-7 (2017)
Animal coloration and behavior can change seasonally, but it is unclear if visual sensitivity to color shifts as well. Here, Shimmura et al. show that medaka undergo seasonal behavioral change accompanied by altered expression of opsin genes, resulti
Externí odkaz:
https://doaj.org/article/de9366e6cdb5411b83b5ab509db1a436
Autor:
Taishi Harada, Tomonari Sasaki, Hidenobu Ishii, Shinnosuke Takemoto, Yasushi Hisamatsu, Haruhiro Saito, Yasuto Yoneshima, Kazutoshi Komiya, Kosuke Kashiwabara, Katsuhiko Naoki, Tomohiro Ogawa, Hiroaki Takeoka, Koichi Saruwatari, Kensaku Ito, Yuko Tsuchiya‐Kawano, Keiko Mizuno, Takayuki Shimose, Yoshiyuki Shioyama, Isamu Okamoto
Publikováno v:
Thoracic Cancer, Vol 15, Iss 29, Pp 2128-2135 (2024)
Abstract Background Concurrent chemoradiotherapy is the standard therapy for locally advanced non‐small cell lung cancer (NSCLC). However, there is little evidence supporting its use in older adults. Low‐dose daily carboplatin combined with thora
Externí odkaz:
https://doaj.org/article/02abb0ebf4f841608cfd2dd4a19fea88
Autor:
Feng-Yu Li, Xin-Ee Tan, Yuzuki Shimamori, Kotaro Kiga, Srivani Veeranarayanan, Shinya Watanabe, Yutaro Nishikawa, Yoshifumi Aiba, Yusuke Sato’o, Kazuhiko Miyanaga, Teppei Sasahara, Sarah Hossain, Kanate Thitiananpakorn, Tomofumi Kawaguchi, Huong Minh Nguyen, Adeline Yeo Syin Lian, Sharmin Sultana, Ola Alessa, Geoffrey Kumwenda, Jayathilake Sarangi, Jastin Edrian Cocuangco Revilleza, Priyanka Baranwal, Mohammad Omar Faruk, Yuya Hidaka, Myat Thu, Mahmoud Arbaah, Anujin Batbold, Maniruzzaman, Yi Liu, Ho Thi My Duyen, Takashi Sugano, Nayanjin Tergel, Takayuki Shimojyo, Longzhu Cui
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-11 (2024)
Abstract In response to the escalating antibiotic resistance in multidrug-resistant pathogens, we propose an innovative phagemid-based capsid system to generate CRISPR-Cas13a-loaded antibacterial capsids (AB-capsids) for targeted therapy against mult
Externí odkaz:
https://doaj.org/article/bb362cf4ba624f929db8a29a2ce1e489
Autor:
Yuzuki Shimamori, Xin-Ee Tan, Feng-Yu Li, Yutaro Nishikawa, Shinya Watanabe, Teppei Sasahara, Kazuhiko Miyanaga, Yoshifumi Aiba, Srivani Veeranarayanan, Kanate Thitiananpakorn, Huong Minh Nguyen, Anujin Batbold, Tergel Nayanjin, Adeline Yeo Syin Lian, Sarah Hossain, Tomofumi Kawaguchi, Ola Alessa, Geofrey Kumwenda, Jayathilake Sarangi, Jastin Edrian C. Revilleza, Priyanka Baranwal, Mahmoud Arbaah, Maniruzzaman, Liu Yi, Ho Thi My Duyen, Takashi Sugano, Sharmin Sultana, Mohammad Omar Faruk, Yuya Hidaka, Myat Thu, Takayuki Shimojyo, Kotaro Kiga, Longzhu Cui
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract In response to the escalating global threat of antimicrobial resistance, our laboratory has established a phagemid packaging system for the generation of CRISPR-Cas13a-antimicrobial capsids targeting methicillin-resistant Staphylococcus aure
Externí odkaz:
https://doaj.org/article/89e20191ded34cbbb0f51b583319b39a
Autor:
Toshiya Nishimura, Tomoya Nakayama, Takumi Senga, Ai Shinomiya, Takashi Yoshimura, Tsuyoshi Shimmura, Yusuke Takehana, Mana Nakatsukasa, Kiyoshi Naruse, Yuko Furukawa, Kousuke Okimura, Minoru Tanaka, Kataaki Okubo, Takayuki Shimo, Yasuhiro Kamei
Publikováno v:
Nature Ecology & Evolution. 3:845-852
To cope with seasonal environmental changes, animals adapt their physiology and behaviour in response to photoperiod. However, the molecular mechanisms underlying these adaptive changes are not completely understood. Here, using genome-wide expressio
Publikováno v:
Journal of the Taiwan Institute of Chemical Engineers. 94:37-42
Expression of non-Newtonian fluid/solid mixture is often encountered in the fields of polymer and food industries. However, a reliable method for the design of the expression process has not been established. In this study, we conducted expression ex
Autor:
Masaki Yasugi, Tsuyoshi Shimmura, Kiyoshi Naruse, Ai Shinomiya, Takashi Yoshimura, Takayuki Shimo, Toshiya Nishimura, Minoru Tanaka, Tomoya Nakayama, Takumi Senga, Shoji Fukamachi, Eiji Watanabe, Yasuhiro Kamei
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-7 (2017)
Nature Communications
Nature Communications
To cope with seasonal changes in the environment, organisms adapt their physiology and behavior. Although color perception varies among seasons, the underlying molecular basis and its physiological significance remain unclear. Here we show that dynam
Autor:
Tomoya, Nakayama, Tsuyoshi, Shimmura, Ai, Shinomiya, Kousuke, Okimura, Yusuke, Takehana, Yuko, Furukawa, Takayuki, Shimo, Takumi, Senga, Mana, Nakatsukasa, Toshiya, Nishimura, Minoru, Tanaka, Kataaki, Okubo, Yasuhiro, Kamei, Kiyoshi, Naruse, Takashi, Yoshimura
Publikováno v:
Nature ecologyevolution. 3(5)
To cope with seasonal environmental changes, animals adapt their physiology and behaviour in response to photoperiod. However, the molecular mechanisms underlying these adaptive changes are not completely understood. Here, using genome-wide expressio
Autor:
Hidenobu Ishii, Koichi Azuma, Takayuki Shimose, Hiroshige Yoshioka, Takayasu Kurata, Naoki Shingu, Masaki Okamoto, Yosuke Kawashima, Isamu Okamoto
Publikováno v:
Thoracic Cancer, Vol 14, Iss 1, Pp 105-107 (2023)
Abstract Background Recently, the addition of antiprogrammed cell death‐ligand 1 (PD‐L1) monoclonal antibodies, including durvalumab and atezolizumab to platinum‐based chemotherapy, has demonstrated clinical benefits in patients with untreated
Externí odkaz:
https://doaj.org/article/4d675f91827b44ba91532c386bfc766c
Autor:
Yoshimasa Shiraishi, Junji Kishimoto, Takayuki Shimose, Yukihiro Toi, Shunichi Sugawara, Isamu Okamoto
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background First-line treatment of nonsquamous non–small cell lung cancer (NSCLC) has undergone a paradigm shift to platinum combination therapy together with immune checkpoint inhibitors (ICIs). However, phase III studies of combinations
Externí odkaz:
https://doaj.org/article/fad4a98eec924a8eac91b100e7450863